BenchSci uses machine learning and artificial intelligence to accelerate biomedical discoveries.
BenchSci has raised $69.6M in total funding. The most recent round was Series D. The last funding was announced in May 2023.
BenchSci's investors include Inovia Capital, TCV, Radical Ventures, Northleaf Capital Partners, Generation Investment Management.
BenchSci is headquartered in Toronto, Canada.
BenchSci uses machine learning and artificial intelligence to accelerate biomedical discoveries.
BenchSci is at the Series D stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"BenchSci — Funding & Investors." VCBacked, May 25, 2023, https://www.vcbacked.co/company/benchsci. Accessed August 13, 2026.
VCBacked. (2023). BenchSci — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/benchsci
{{cite web |title=BenchSci — Funding & Investors |url=https://www.vcbacked.co/company/benchsci |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated